Continence Aids Payment Scheme 2020

This Instrument organises a narrowly defined subsidy around a capped annual cash payment and a set of administrative controls. The main statutory concepts are as follows.

Eligibility and “permanent and severe incontinence”: Eligibility is two-tiered. Medical eligibility requires permanent and severe incontinence as defined in s 4(1): “frequent and uncontrollable moderate to large loss of urine or faeces which impacts on a person’s quality of life and which is unlikely to improve with medical, surgical or clinical treatment regimes.” This clinical formulation is coupled with a list-based approach: the Instrument relies on two schedules, “eligible neurological condition” (Part 1) and “eligible other condition” (Part 2), enumerating specific diagnoses that cause incontinence (s 5(1)(a); Schedule Parts 1 and 2).

Means/status linkage: Access is tied to social security and veterans’ concession card status. Under s 5(1)(a)(ii)-(iii), persons must either hold or be dependants of holders of a Pensioner Concession Card under the Social Security Act 1991, or hold/ be dependants of holders of a DVA Pensioner Concession Card in the circumstances specified. Thus the Instrument layers a medical qualifying condition with a welfare/status gate.

Excluded cohorts: The Instrument expressly excludes transient incontinence, children under five, many aged care recipients receiving residential care or home care packages that include continence aids, NDIS participants with an NDIS plan that includes consumables for continence aids, people eligible for DVA assistance for continence aids under the Rehabilitation Appliances Program, persons who have lived outside Australia continuously for three years, and those serving a prison sentence (s 5(2)(a)-(g)). These exclusions prevent overlap with other care funding streams and with specified categories of residential or programmatic support.

Payment structure and cap: The core subsidy is a non-indexed, annually specified CAPS payment ($717.10 per s 11(1)). Pro rata treatment and single-claim limitations are set out (s 11(2)-(3)). Payment timing, instalment options and methods (EFT to nominated bank account) are specified (ss 12-13). The payment can be made to the participating person, an authorised payment recipient, or to the estate if the person has died (s 12(1)).

Administrative evidence and certification: Applications require completion on an approved form and a statement prepared and signed by a health professional certifying that the applicant has been diagnosed by a doctor with an eligible condition which has caused permanent and severe incontinence (s 6(2)(b)-(c)(i)). The Instrument defines “health professional” and excludes family members from acting as the certifying health professional (s 4(1): health professional definition and exclusion).

Agents, organisations and fiduciary-like obligations: The Instrument recognises three distinct roles to manage communications and payments: authorised representative (s 18), correspondence recipient (s 19), and authorised payment recipient (s 20). Organisations may act as authorised payment recipients if authorised in the approved form (s 22(2)). Organisations that receive payments as agents have express obligations to assist participating persons, to apply payments as contributions towards purchasing aids, to notify of unused funds, to refund unused portions (including to estates) and to keep and retain records (s 22(4)-(6)). The Secretary can direct denial of payments to an organisation where the arrangement is not operating to the benefit of the participating person or where obligations are not complied with (s 22(7)).

Monitoring, recovery and review: The Chief Executive Medicare may investigate eligibility (s 24). Incorrectly paid amounts are recoverable as debts to the Commonwealth (s 23). The Instrument provides internal review paths to the Chief Executive Medicare (s 25) for decisions under ss 6 and 9, and Secretary decisions under ss 21 and 22(7) are reviewable internally and by the Administrative Review Tribunal (s 26).

Schedules as operative law: The Schedule is not descriptive only; it operates to define eligibility. Conditions listed are determinative of the medical qualification axis. Practically, whether a diagnosis appears in the Schedule matters directly to eligibility under s 5(1)(a)(i)-(ii).

Together, these concepts form a mechanism: a list-and-status-gated, modest capped cash contribution administered via Medicare, with statutory obligations and record-keeping for organisations acting as agents and multiple administrative gates and review paths. The Instrument embeds interaction points with other Commonwealth programs and statutes (for example Social Security Act, NDIS Act 2013, Aged Care Act 1997 and veterans’ entitlements law), and it places procedural emphasis on approved forms, certified medical statements, and Secretary/Chief Executive discretion to approve or refuse representations, payments and organisations.

This Instrument affects a tight set of actors in defined ways. State party identification and the nature of the effect follow directly from the text.

Participating persons and applicants (primary private beneficiaries): A “participating person” is a person approved under s 6 to participate or taken to participate under the Amendment Act (s 4(1): participating person). The participating person is the legal recipient of the CAPS payment (s 12(1)(a)) unless they have nominated an authorised payment recipient or another arrangement applies. To be affected, the person must meet both the medical condition test (permanent and severe incontinence caused by an eligible condition listed in the Schedule) and the status test (Pensioner Concession Card holder or dependant, or DVA concession card holder in specified circumstances) under s 5(1). Exclusions in s 5(2) specifically remove certain cohorts from eligibility, including children under five, many aged care recipients whose care includes continence aids, NDIS participants with relevant plan coverage, and persons eligible for DVA Rehabilitation Appliances Program assistance.

Dependants and families: Dependants of Pensioner Concession Card or DVA Pensioner Concession Card holders can be participating persons under s 5(1)(a)(ii)-(iii). The definition of “family member” in s 4(1) matters for who can be treated as relations for purposes of authorised representatives or care arrangements; however, the Instrument distinguishes family members from “health professionals” who must not be family members when certifying medical statements (s 4(1): health professional).

Health professionals and doctors: Health professionals provide the required certificate in the approved form certifying a doctor’s diagnosis of an eligible condition which has caused permanent and severe incontinence (s 6(2)(c)(i)). The Instrument’s definition of “health professional” (s 4(1)) includes persons registered under Commonwealth, State or Territory law or eligible Aboriginal health workers under a separate determination, but disqualifies family members from acting in that role.

Organisations and suppliers of continence aids: Entities with an Australian Business Number that provide or facilitate provision of continence aids can act as authorised payment recipients if authorised in the approved form and if they accept the role (s 4(1): definition of organisation; s 20(1)(d); s 22(2)-(3)). Organisations authorised to receive CAPS payments assume several statutory obligations (s 22(4)-(6)), including assisting the participating person to obtain appropriate aids, informing participating persons about unused amounts, refunding unused amounts to estates or the participating person under specified circumstances, and retaining detailed records for specified retention periods.

Legal representatives, authorised representatives, payment nominees and correspondence recipients: Legal representatives (guardians, attorneys) are recognised in multiple provisions (s 4(1): legal representative). An assisted person may have an authorised representative in the absence of a legal representative (s 18). A correspondence recipient may be authorised to receive correspondence on behalf of an applicant or participating person (s 19). Separate statutory pathways exist for payment nominees recognised under social security or veterans’ law to receive CAPS payments as authorised payment recipients (s 20(1)(a)-(b)). The Secretary may approve a “responsible person” to act as authorised representative or authorised payment recipient, with prescribed preconditions and revocation ability (s 21).

Administrators and officials: The Chief Executive Medicare is the decision-maker for participation approvals, payment execution, investigations and debt recovery (ss 6; 12; 24; 23). The Secretary (or delegate) has approval, revocation and direction powers regarding responsible persons and organisations, and can direct the Chief Executive Medicare to decline payments to organisations (ss 21; 22(7)). Both the Chief Executive Medicare and the Secretary are obliged to give written notices with reasons and advise of review rights in particular decisions (notes cross-referencing ss 14 and 15 of the National Health Act and s 26(2)).

Third-party payees and estates: If a participating person dies, payments are made to the estate (s 12(1)(c)); organisations must refund unused portions to the estate (s 22(4)(d)). The law therefore implicates executors and estate law processes to the extent payment recovery or refund is necessary.

Other Commonwealth programs and scheme administrators: The Instrument explicitly interacts with social security law (Pensioner Concession Card under the Social Security Act 1991) and with the NDIS (exclusion where an NDIS plan includes consumables covering continence aids, s 5(2)(d)), with the Aged Care Act 1997 (residential care definitions and exclusions, s 5(2)(c)), and with DVA programs (s 5(2)(e)). Administrators of those programs will be affected operationally because their decisions or classifications can determine whether a person is eligible or excluded from CAPS.

Who pays and who decides: The Commonwealth (via Medicare, represented by the Chief Executive Medicare) pays the CAPS payment (s 12(1)-(2)). The Chief Executive Medicare and the Secretary make the key administrative decisions , approving participation (s 6), making determinations that eligibility has ceased (s 9), conducting investigations (s 24), approving responsible persons and organisations (s 21; s 22(3)), and directing payment denial to organisations (s 22(7)). Participating persons, applicants, legal representatives and nominated agents must take action to apply, nominate bank accounts, notify changes of circumstances, and comply with statutory obligations such as timely notification of ineligibility (ss 6; 7; 8).

In short, the Instrument affects a small, medically defined beneficiary population and a set of intermediaries (health professionals, organisations supplying aids, legal and authorised representatives) plus Commonwealth administrators who control eligibility, payments and oversight.

The Instrument establishes a set of procedural duties for applicants, participating persons, authorised representatives and organisations, and grants specific rights, including payment entitlements and review rights. Key statutory duties and rights follow the text.

Duties of applicants and participating persons

• Application on the approved form: Applicants must apply on the approved form and include the documents required by that form, including a health professional statement certifying a doctor’s diagnosis of an eligible condition causing permanent and severe incontinence (s 6(2)(b)-(c)(i)). The definition of “approved form” is in s 4(1).
• Notification obligations: Participating persons, legal representatives or authorised representatives must promptly notify the Chief Executive Medicare when the participating person no longer meets eligibility criteria or becomes aware that they no longer meet criteria (s 7(1)) and must notify promptly if a participating person dies (s 7(2)). Section 8 requires prompt notification of events or changes affecting eligibility, or of knowledge that such an event is likely to occur (s 8).
• Election of payment instalments and bank account details: If a person elects instalments, they must do so in the approved form; bank account details for EFT must be notified on the approved form (s 12(2)(a)-(b); s 13(1)).

Rights of participating persons

• Entitlement to CAPS payment if approved: An approved person is entitled to the specified CAPS payment as set out in s 14(2) and s 11(1) (or pro rata amount s 11(2)) for the financial year in which the application is approved and for subsequent years so long as participation has not ceased before 1 July of a financial year (s 14(2)-(3)).
• Payment timing rights: For participating persons on 1 July, a payment must be made by 30 July or by instalments according to s 13(2) (s 14(3)(a)(i)-(ii)); for approvals after 1 July but before 31 December, payment must be within 30 days of approval (s 14(3)(b)); approvals after 31 December must be paid within 30 days (s 14(3)(c)).
• Receipt and notification: The Chief Executive Medicare must provide a written statement with payment details to the participating person or correspondence recipient, and to an organisation if payment was made to an organisation (s 15(1)).

Duties and obligations of representatives and agents

• Authorised representatives: An authorised representative must act in the interests of the assisted person at all times (s 18(4)). The Instrument sets out who can be an authorised representative in the absence of a legal representative (s 18(2)-(3)).
• Authorised payment recipients: To receive payments as agents, nominees must be notified to the Chief Executive Medicare in the approved form and not be contradicted by the legal representative (s 20(2)). Authorised payment recipients (including organisations) then receive payments on behalf of participating persons (s 20(3)).
• Responsible persons: The Secretary may approve an individual as authorised representative and/or authorised payment recipient subject to the Secretary being satisfied that certain conditions are met: the legal representative or other representative does not oppose the approval (if one exists), that the individual provides care or assistance, that the arrangement benefits the person, and that the individual will use funds only for their intended purpose. The Secretary can revoke approval if appropriate, having regard to the same matters (s 21(1)-(3)).

Specific obligations on organisations receiving payments (s 22)

• Assist the participating person to obtain appropriate continence aids (s 22(4)(a)).
• Assist the participating person to use the CAPS payment as a contribution toward the cost of continence aids (s 22(4)(b)).
• Inform the participating person of any unused CAPS payment amount 30 days before the end of the financial year to which the payment relates (s 22(4)(c)).
• Refund unused portions to the participating person (s 22(4)(e)-(f)) or to the estate when the participating person has died (s 22(4)(d)).
• Inform the Chief Executive Medicare promptly on becoming aware that the participating person does not meet the eligibility criteria (s 22(4)(g)).
• Record-keeping: keep collated accessible records with details of amounts received, dates and how amounts were used, and retain them for three years after 30 June of the year the record was made (s 22(5)(a)-(b)).
• Provide details on use of a CAPS payment if requested by the participating person or authorised representative (s 22(6)).

Duties and rights of officials

• Approval duty: The Chief Executive Medicare must approve an applicant who meets eligibility criteria and submits the approved form with required documents (s 6(2)(a)-(c)).
• Investigation power: The Chief Executive Medicare may conduct investigations to ensure eligibility (s 24).
• Determination power: If satisfied a participating person does not meet eligibility criteria (when notification has not been given), the Chief Executive Medicare must make a written determination that the person is not eligible and specify when eligibility ceased (s 9).
• Recovery power: Amounts paid to which a person was not entitled are debts recoverable by Chief Executive Medicare (s 23).
• Secretary’s decision duties: Decisions to approve or revoke responsible persons or to direct payment denial to organisations trigger notice and internal review rights; the Secretary must give a signed written notice stating reasons and review rights (s 26(2)-(6)).

Review rights and procedural protections

• Reconsideration by Chief Executive Medicare: Persons aggrieved by decisions under s 6 or s 9 may apply in writing to the Chief Executive Medicare for review within 28 days of receiving notice (s 25(1)-(2)).
• Review of Secretary’s decisions: Decisions under s 21(1) and (3) and s 22(7) are subject to internal review by the Secretary and external merits review by the Administrative Review Tribunal (s 26(1), (4)-(7)). The Secretary must give written notice that includes reasons and advice about applying for review (s 26(2)(c)-(d)).

Limits on entitlement and payment control

• Maximum one CAPS payment per financial year and no more than the amount specified in s 11(1) (s 11(3)(a)-(b)).
• Instalment restrictions: a second instalment must not be paid if participation has ceased before January in the financial year (s 13(5)).

In sum, the Instrument creates entitlements (capped annual payments) conditional on combined medical and concession card status, sets application and certification duties, imposes record-keeping, notification and refund duties on organisations acting as agents, and affords applicants and affected organisations structured review rights. Officials have investigatory, debt-recovery and discretionary approval powers constrained by notice and internal/external review procedures.

The Instrument frames enforcement primarily through administrative determinations, recovery of improperly paid funds, and suspension or refusal of payments rather than by criminal sanction. The specific enforcement mechanisms and statutory penalties are as follows.

Debt recovery (financial enforcement)

• Section 23 provides a clear financial enforcement mechanism: amounts paid to a participating person or former participating person to which they were not entitled, whether paid directly or through an agent, are debts due to the Commonwealth and recoverable by the Chief Executive Medicare. The provision creates an enforceable Commonwealth debt rather than a criminal penalty. It attaches to the participant and, to the extent funds have been disbursed to agents, can be recovered from the recipient. The Instrument does not specify the recovery procedures (seizure, offset, litigation) in detail; it simply states the amount is a recoverable debt. The particular collection powers used would therefore follow Commonwealth debt-recovery rules and administrative practice outside this Instrument.

Administrative refusal and direction (payment suspension)

• Section 22(7) empowers the Secretary to direct the Chief Executive Medicare in writing to decline to make a CAPS payment to an organisation if satisfied that the arrangement is not operating to the benefit of the participating person or the organisation has not complied with obligations imposed by the Instrument in respect of any participating person. The Chief Executive Medicare must comply where such a direction is given (s 22(8)). This is a non-criminal administrative sanction that can withdraw an organisation’s access to CAPS funds.

Revocation of approvals

• The Secretary may revoke approval of responsible persons if satisfied that revocation is appropriate, taking account of the matters in s 21 (s 21(3)). Revocation terminates an individual’s ability to act as an authorised representative or authorised payment recipient under the Scheme. This is an administrative sanction linked to representation and payment receipt roles.

Investigations and determinations of ineligibility

• Section 24 permits the Chief Executive Medicare to conduct investigations “as he or she thinks appropriate” to ensure eligibility. Where the Chief Executive Medicare is satisfied that a participating person does not meet eligibility criteria and notification has not been given, the Chief Executive Medicare must make a written determination setting out that the person is not eligible and the date eligibility ceased (s 9). That determination affects entitlement to future payments and, combined with s 23, can lead to recovery for amounts already paid.

Procedural enforcement through notices and review

• Where decisions are made under the Instrument (for example decisions under s 6 or s 9, or Secretary decisions under s 21 and s 22(7)), the Chief Executive Medicare or the Secretary must give a signed notice including reasons for the decision and advice that the person may apply for review. Internal review windows are set (generally 28 days) and external merits review by the Administrative Review Tribunal is available for Secretary decisions (s 25; s 26). These procedural requirements constrain the exercise of sanctions and provide an administrative channel to contest actions.

Record-keeping obligations with retention periods

• Organisations that receive CAPS payments as agents must collate and retain records containing details of amounts received, dates received, and usage, and must retain those records for the period ending three years after 30 June of the year in which the record was made (s 22(5)). Failure to maintain or produce these records can expose organisations to an s 22(7) finding and consequent denial of payments.

Refund obligations

• Organisations must refund unused portions of a CAPS payment to the participating person on notification of ceased eligibility or termination of the arrangement, and must refund to an estate where the participating person has died (s 22(4)(d)-(f)). Failure to refund as required is a breach subject to a Secretary direction under s 22(7) and, where funds were improperly paid, to debt recovery under s 23.

No express criminal penalties in instrument

• The Instrument contains no specific criminal offences or penal fines. Enforcement is via administrative directions (denial or revocation of payments or approvals), debt recovery, investigatory powers, and procedural review. Any criminal or civil sanction beyond debt recovery would need to be sought under other Commonwealth laws or via civil procedures outside the Instrument.

Practical enforcement sequence

• In practice the sequence would typically be investigation (s 24), determination that we no longer have eligibility (s 9), notice and internal review opportunity (s 9 note; s 25), debt assessment and recovery (s 23) where overpayments are identified, and possible direction to deny payments to an organisation if the organisation’s practices are non-compliant (s 22(7)). Secretary decisions are subject to internal review and external merits review (s 26).

Record of reasons and review rights

• The Instrument requires written reasons for the Secretary’s decisions and time-limited internal review rights, and it references the Administrative Review Tribunal for external merits review (s 26(2)-(7)). These procedural protections limit arbitrary enforcement but insert administrative workload and timelines for affected parties.

In short, enforcement is administrative and financial: debt recovery under s 23, suspension or refusal of payments to organisations under s 22(7), revocation of approvals under s 21(3), and investigatory and determinate powers under ss 9 and 24, all subject to internal and, in some cases, external review.

The Instrument explicitly cross-references and incorporates other Commonwealth statutes and programs. Those intersections define eligibility boundaries, roles, and procedural cross-checks. The principal interactions are as follows.

National Health Act 1953 and delegated administration

• The Instrument is made with reference to the National Health Act 1953 (the Act), and several procedural notes in the Instrument cross-reference sections of that Act. The Instrument’s definitions and delegations are to operate within the broader administrative framework of the National Health Act: see the definition of “Act” in s 4(1) and the cross-references in notes to ss 6, 9 and 26 which reference sections 14 and 15 of the Act about notices when applications are refused (s 6 note; s 9 note). The Chief Executive Medicare’s procedural duties and notices are framed in that larger statutory environment.

Social Security Act 1991 (Pensioner Concession Card and representation)

• Eligibility is explicitly coupled to the Pensioner Concession Card issued under Division 1 of Part 2A.1 of the Social Security Act 1991 (s 5(1)(a)(ii)). The Instrument also treats social security law representation statuses and payment nominees as relevant for authorised representatives and authorised payment recipients (s 18(2)(a); s 20(1)(a)), and notes the use of correspondence nominees appointed under s 123C of the Social Security (Administration) Act 1999 (s 18(2)(a) note). The Scheme therefore uses social security entitlements and administrative categories as eligibility and representation gates.

Aged Care Act 1997 (definitions of residential and respite care)

• The Instrument borrows definitions of “residential care”, “residential care service” and “respite care” from the Aged Care Act 1997 for exclusion rules (s 4(1) definitions; s 5(2)(c)). Care recipients receiving residential care or home care packages that include continence aids are excluded where the care arrangement covers continence aids (s 5(2)(c)). This avoids duplication where aged care funding is already providing continence aids.

National Disability Insurance Scheme Act 2013 (NDIS interactions)

• NDIS participants with active NDIS plans that include a consumables budget covering continence aids are excluded from CAPS (s 5(2)(d)). The Instrument expressly defers to NDIS plan coverage for consumables to avoid funding overlap. The definition of “NDIS participant” and “NDIS plan” are given in s 5(5) referencing the NDIS Act.

Veterans’ entitlements and DVA programs

• The Instrument references Department of Veterans’ Affairs entitlements in two ways: first, persons who have a DVA Pensioner Concession Card or entitlement (primary cardholder or dependant) may be eligible under s 5(1)(a)(iii); second, persons eligible to receive assistance under the Rehabilitation Appliances Program through DVA are excluded from CAPS under s 5(2)(e). The Instrument also recognises DVA trustees and veterans’ payment nominees for representation and payment receipt (s 18(2)(b); s 20(1)(b)) and cross-references veterans’ entitlements law.

Acts Interpretation Act 1901

• A note in s 4(1) refers to s 10 of the Acts Interpretation Act 1901 regarding references to amended or replaced legislation, indicating that references within the Instrument should be read in light of standard interpretation rules.

Administrative Review Tribunal (merits review)

• The Instrument provides for external merits review by the Administrative Review Tribunal of certain Secretary decisions (s 26(7)), and notes in s 25 that sections 14 and 15 of the Act provide for reconsideration by the Chief Executive Medicare and review by the Administrative Review Tribunal. This embeds access to merits review under the Administrative Review Tribunal Act (as applicable) for certain decisions.

Retention and record-keeping frameworks and privacy/commercial law (implicit)

• The Instrument requires organisations to retain collated records for three years after 30 June of the year the record was made (s 22(5)(b)). While the Instrument does not explicitly cross-reference privacy law, the record-keeping requirement will engage Commonwealth privacy duties and any applicable State/Territory privacy or records legislation and commercial accounting obligations in practice.

Estate law

• Payments to estates on death (s 12(1)(c); s 22(4)(d)) implicate State/Territory succession law practices in the distribution of funds to executors or administrators. The Instrument requires organisations to refund unused portions to estates; administering those refunds will follow local estate administration rules not spelled out in the Instrument.

Debt recovery and Commonwealth collection law

• Section 23 makes overpayments a debt to the Commonwealth and recoverable by the Chief Executive Medicare. The mechanics of recovery (administrative garnishee, offsets against future payments, legal proceedings) are not detailed in the Instrument but will operate via Commonwealth collection procedures and potentially the Commonwealth’s general debt recovery and litigation processes.

Interplay with approvals and representation under other laws

• The Instrument recognises legal representatives appointed under State and Territory law and draws a distinction between legal representatives and authorised representatives created under the Instrument (s 4(2)-(3); s 18). Where a person has a legal representative, that legal representative’s views constrain the Secretary’s approval of responsible persons (s 21(2)(a)). The Instrument explicitly states that nothing in it is intended to affect the operation of State or Territory laws dealing with legal representatives (s 4(2)).

Transitional provisions and later amendments

• Section 27 preserves transitional application of the prior Instrument’s provisions to persons eligible immediately before 1 October 2022 until 30 June 2023, despite eligibility amendments in the 2022 Eligibility Instrument (s 27). The Instrument therefore interacts with its own amendment history and subsequent instruments.

In practice the Instrument is tightly interwoven with social security, aged care, NDIS and DVA entitlement frameworks. That linkage produces operational gates (e.g. exclusions where other programs fund continence aids), channels for representation (social security nominees, DVA trustees), and reliance on medical certification and administrative data held under those other programs. The Instrument defers to other funding streams in a number of places, using exclusions to prevent overlap, and relies on cross-program administrative categories for representation and nomination roles.

The Instrument itself gives a concise set of references to its origins and later amendments; the following history is confined to what the Instrument text supplies.

Original formulation and continuation

• The Instrument expressly maintains in existence the Continence Aids Payment Scheme formulated by the Continence Aids Payment Scheme 2010. Section 1 gives the Instrument’s name as the Continence Aids Payment Scheme 2020 and s 3(2) states that this Instrument maintains in existence the Scheme formulated by the 2010 instrument. That establishes the lineage from the 2010 instrument to this 2020 instrument.

Reference to Amendment Act 2010

• The Instrument defines “Amendment Act” to mean the National Health Amendment (Continence Aids Payment Scheme) Act 2010 (s 4(1) definition). The Amendment Act is also used substantively in s 5(3) and in the definition of “participating person” (s 4(1) participating person), where a person may be “taken to participate, and to be eligible to participate, in the Scheme under item 3 of the Amendment Act,” and where the Instrument notes that section 10 of the Instrument deals with when a person’s participation ceases to have effect. The text therefore incorporates the effect of the 2010 Amendment Act on prior participants.

Reference to Continence Aids Payment Scheme Variation 2011 (No.2)

• Section 5(3) and (4) reference persons who applied to participate between 1 July 2010 and commencement of the Continence Aids Payment Scheme Variation 2011 (No.2), and provides a special CAPS payment calculation consequence for persons eligible under s 5(1)(a)(iii) who applied in that period. This indicates a discrete subsequent variation in 2011 that affected the application of payment calculations and eligibility timing.

Continence Aids Payment Scheme Amendment (Eligibility) Instrument 2022

• Section 27 addresses the effect of a 2022 instrument. It provides that for persons who were eligible immediately before 1 October 2022, the Instrument as in force immediately before 1 October 2022 continues to apply to the person until 30 June 2023 despite amendments made by Schedule 1 to the Continence Aids Payment Scheme Amendment (Eligibility) Instrument 2022. This is a transitional saving provision to preserve the previous eligibility entitlements for a limited period for those already eligible.

No other amendments listed in the text

• The Instrument’s text does not list any further amendment dates, indexation adjustments or legislative changes beyond the 2010 origin, the 2011 variation, and the 2022 eligibility instrument transitional provision. The Instrument fixes the CAPS payment at $717.10 in s 11(1); there is no provision within the Instrument for automatic indexation or scheduled periodic adjustment contained in the text provided.

Operational implication of amendment references

• The references to the 2010 Act and the 2011 variation indicate the Scheme sits in a history of periodic legislative refinement; the 2022 transitional clause demonstrates the legislative practice of phasing eligibility amendments to avoid immediate displacement of existing participants. Section 4(1) notes that s 10 of the Acts Interpretation Act 1901 deals with references to legislation that has been amended or replaced, which governs interpretation of those cross-references.

In short, the Instrument continues the 2010 Scheme, records a 2011 variation as relevant to a historical cohort, and provides transitional savings for eligibility amendments made in 2022 for persons already in the Scheme as at 1 October 2022 until 30 June 2023. The Instrument itself sets the current payment quantum and operational rules as at the time it was made.

The Instrument does not record or reference any litigation. The text names no cases and contains no judicial decisions or citations. The only dispute-resolution mechanisms provided within the Instrument are administrative and merits-review avenues.

Administrative review and merits review pathways provided

• The Instrument gives persons aggrieved by decisions under s 6 or s 9 the right to apply to the Chief Executive Medicare for review of the decision within 28 days of receiving notice (s 25(1)-(2)). It also provides internal review procedures and external merits review by the Administrative Review Tribunal for Secretary decisions under ss 21(1), 21(3) and 22(7) (s 26(1), (4)-(7)). The Secretary must provide reasons and advice about review rights in notices (s 26(2)).

No court decisions or litigation examples

• There are no references to cases, litigation precedents, or judicial interpretations in the Instrument. Any judicial challenges or case law concerning the operation or interpretation of the Instrument would appear outside the Instrument text and are not provided here.

Practical implications

• Because the Instrument provides internal reconsideration and external merits review channels, most disputes over eligibility determinations, Secretary approvals/revocations and payment denial directions are intended to be addressed administratively and by merits review before the Administrative Review Tribunal. If a party wishes to pursue judicial review (e.g. in the Federal Court) that route is not referenced here and would be governed by general administrative law (judicial review) principles outside the Instrument’s text. The Instrument’s silence on litigation means practitioners must look to administrative law jurisprudence and the decisions of the Administrative Review Tribunal and courts for any interpretative or compliance precedents. None are cited in the Instrument.

This section highlights traps and operational details that commonly cause non-compliance or confusion, drawn strictly from the Instrument’s text.

1. Medical certification must be by a health professional and cannot be a family member

• The application must include “a statement prepared and signed by a health professional certifying that the applicant has been diagnosed by a doctor with an eligible neurological condition or eligible other condition … which has caused permanent and severe incontinence” (s 6(2)(c)(i)). The Instrument defines “health professional” and explicitly excludes a family member of the participating person (s 4(1): health professional). Practical consequence: a spouse, parent or child cannot provide the medical certification; the certifier must be a registrable health practitioner or eligible Aboriginal health worker as defined.

2. Eligibility is a compound test: medical plus concession card status

• Satisfying the medical schedule alone does not produce entitlement. The applicant must also have (or be the dependant of) a Pensioner Concession Card under the Social Security Act, or have or be a dependant of a DVA Pensioner Concession Card holder in the circumstances specified (s 5(1)(a)(ii)-(iii)). Applicants who meet the medical test but lack the required concession card status are not eligible under s 5(1).

3. Exclusions that can be overlooked

• The Instrument excludes NDIS participants where an NDIS plan is in effect and includes a consumables budget that covers continence aids (s 5(2)(d)); this is an immediate disqualifier to prevent overlap. Similarly, people who receive residential care where continence aids are part of the care arrangement, or those whose home care package includes continence aids, are excluded (s 5(2)(c)(i)-(ii)). People eligible for DVA Rehabilitation Appliances Program assistance are excluded (s 5(2)(e)). Practitioners must check those funding arrangements before applying.

4. Children under five are excluded

• Children under five years old are explicitly ineligible (s 5(2)(b)). That is an absolute age-based exclusion.

5. Overseas residency breaks eligibility

• Australian citizens or permanent residents who have resided outside Australia for a continuous period of three years (including leave in the country of residence) are not eligible (s 5(2)(f)). This can surprise applicants who assume citizenship suffices.

6. Payment can be to an organisation but the organisation faces strict obligations and oversight

• Organisations that receive payments must: assist the participating person to obtain appropriate aids, assist in using the payment as a contribution to purchase aids, notify the participating person of unused funds 30 days before year-end, refund unused amounts to estates or participating persons on specified triggers, inform Chief Executive Medicare promptly if the person is no longer eligible, keep collated accessible records including how funds were used, and retain those records three years after 30 June of the year of the record (s 22(4)-(5)). Failure to comply can lead to Secretary direction to decline payments (s 22(7)). Practitioners should note that accepting payments as an agent creates an ongoing statutory duty and recordkeeping obligation.

7. Payments are fixed and not indexed in the Instrument

• The annual CAPS payment is $717.10 (s 11(1)). The Instrument contains no clause indexing or varying that amount automatically. Where an applicant expects the payment to cover full costs of aids, the cap mechanism limits subsidy; any shortfall falls to the person or their budget.

8. Instalment timing traps

• If a person elects instalments, the first instalment timing depends on whether the person is a participating person on 1 July or applied after 1 July (s 13). Critically, s 13(5) bars payment of a second instalment if participation has ceased before January in the financial year. That means revocation or cessation late in the calendar year can block the second instalment.

9. Approved form is a recurring procedural gateway

• Multiple obligations and elections must be done “in the approved form” (includes application, election to receive instalments, notification of authorised payment recipients, organisation details). Practically, using an incorrect form or incomplete form information will lead to refusal under s 6(2)(b)-(c), and the Chief Executive Medicare must give reasons and review information if refused (s 6 note; s 25).

10. Health professional statement requires a diagnosis “by a doctor” but prepared and signed by a health professional

• The language in s 6(2)(c)(i) requires the statement to certify that the applicant “has been diagnosed by a doctor” with an eligible condition and that the condition has caused permanent and severe incontinence. The statement is “prepared and signed by a health professional.” Practically this creates a two-step evidentiary linkage: a doctor’s diagnosis must exist, but the statement can be prepared and signed by a health professional (not a family member) who certifies the doctor’s diagnosis and the clinical consequence.

11. Notice and review windows are short

• Persons aggrieved by decisions under ss 6 or 9 must apply for review to the Chief Executive Medicare within 28 days after receiving notice (s 25(2)(a)). Secretary decisions also allow 28 days for internal review, unless the Secretary allows a longer period (s 26(5)(b)). Missing the 28‑day window may constrain review options.

12. “Organisations” are defined narrowly

• An “organisation” must have an Australian Business Number and provide, will provide or facilitate provision of continence aids to a participating person, but does not include persons with legal authority under State or Territory law (guardians, attorneys), or certain individuals already covered by ss 18(2)(a)-(c) or 20(1)(a)-(c) (s 4(1) definition). Organisations must provide details in the approved form to receive payments (s 22(3)).

13. Refund and estate obligations require administrative processes

• Organisations are required to refund unused CAPS balances to the estate if the participating person dies (s 22(4)(d)). This creates an ongoing reconciliation obligation and may require engagement with estate administrators.

14. Recovery of overpayments is a Commonwealth debt

• Section 23 makes any amount received to which a person was not entitled a debt due to the Commonwealth and recoverable by the Chief Executive Medicare. Recovery powers may include offsets or legal action outside the Instrument; practitioners should treat overpayments seriously.

15. The Schedule is prescriptive, not illustrative

• The Schedule’s listings of eligible conditions are operative. An applicant’s diagnosis must correspond to an eligible condition listed in the relevant Schedule part for the relevant eligibility pathway (s 5(1)(a)(i)). Assuming a condition is covered without checking the Schedule risks refusal.

These are practical “gotchas” flowing from the Instrument’s wording rather than policy judgements. They point to common operational mistakes: wrong certifier; missing concession card nexus; misreading exclusions relating to NDIS and aged care; organisational compliance and refund requirements; short review windows; and unindexed payment cap.

This section sets out actionable compliance steps for applicants, authorised representatives, organisations and advisers, strictly grounded in the Instrument’s requirements and timelines.

For applicants and potential participating persons

1. Confirm medical eligibility against the Schedule and “permanent and severe incontinence” definition

• Check that the applicant’s diagnosis is one of the conditions listed in the Schedule (Part 1 for eligible neurological conditions or Part 2 for eligible other conditions) and that the incontinence meets the Instrument’s definition of “permanent and severe incontinence” (s 4(1) definition). Do not assume non-listed names will suffice.

2. Verify concession card status (social security or DVA)

• Confirm the person holds a Pensioner Concession Card under Division 1 of Part 2A.1 of the Social Security Act 1991 or is a dependant of a holder, or holds (or is a dependant of a holder of) a Department of Veterans’ Affairs Pensioner Concession Card where that pathway applies (s 5(1)(a)(ii)-(iii)). If the person does not meet the concession-card linkage, do not apply until that status is obtained or clarified.

3. Avoid excluded categories

• Ensure the applicant is not excluded per s 5(2) , notably children under five, residential care recipients whose care includes continence aids, home care package recipients whose care plans include continence aids, NDIS participants whose NDIS plan contains a consumables budget including continence aids, persons eligible for DVA Rehabilitation Appliances Program for continence aids, persons with three continuous years outside Australia, and persons serving a prison sentence.

4. Obtain the correct medical statement and use an approved form

• Complete the approved application form. Obtain a statement “prepared and signed by a health professional” that certifies the applicant “has been diagnosed by a doctor” with an eligible condition that has caused permanent and severe incontinence (s 6(2)(c)(i)). Ensure the certifying health professional is not a family member (s 4(1): health professional). Keep supporting medical records in case of an investigation (s 24).

5. Lodge the approved form and provide bank details

• Lodge the application on the approved form with all required documents and nominated bank account details for electronic funds transfer (s 6(2)(b); s 12(2)(b)). If electing instalments, make the election on the approved form (s 12(2)(a); s 13(1)).

6. Monitor entitlement dates and instalment rules

• If applying after 1 July, understand the pro rata calculation and instalment timing rules in s 11(2) and s 13. Be aware the second instalment will not be paid if participation ceases before January (s 13(5)).

7. Timely notifications of changes and death

• Notify the Chief Executive Medicare promptly if the participating person ceases to meet eligibility criteria (s 7(1)) or dies (s 7(2)). Also notify promptly of any event or change likely to affect eligibility (s 8) to avoid liability under s 23 for payments not properly due.

For legal representatives and authorised representatives

1. Establish legal authority and provide correct notifications

• If acting as a legal representative (guardian/attorney under State/Territory law), ensure that legal authority is recorded and that any nominations to receive payments or correspondence are made in the approved form as required (s 20(2)). Legal representatives can notify the Chief Executive Medicare to nominate other persons to receive payments; where a legal representative exists, the Chief Executive Medicare must not pay another nominated recipient if notified to the contrary (s 20(2)(b)).

2. Act in the participant’s best interests

• Authorised representatives must act in the interests of the assisted person at all times (s 18(4)). The Secretary will consider whether an arrangement is for the benefit of the person when approving responsible persons (s 21(2)(c)).

For organisations accepting payments as authorised payment recipients

1. Register and complete the approved form

• If an organisation agrees to receive CAPS payments as agent, it must provide details to the Chief Executive Medicare in the approved form (s 22(2)-(3)) and must have an Australian Business Number (s 4(1): organisation definition).

2. Implement internal controls to meet statutory obligations

• Establish processes to assist participating persons to obtain appropriate continence aids and to use CAPS payments as intended (s 22(4)(a)-(b)). Ensure procedures to notify participating persons of unused CAPS amounts 30 days before the financial year ends (s 22(4)(c)). Implement refund procedures for unused amounts to participating persons upon notification of ceased eligibility or termination and for estates on death (s 22(4)(d)-(f)). Timely notification to Chief Executive Medicare where a person ceases to meet eligibility is required (s 22(4)(g)).

3. Record-keeping and retention

• Maintain collated accessible records detailing amounts received, dates and how amounts were used (s 22(5)(a)(i)-(iii)). Retain records for three years after 30 June of the year the record was made (s 22(5)(b)). Be prepared to provide details on use when requested by the participating person or their authorised representative (s 22(6)).

4. Anticipate Secretary oversight and potential payment denial

• Non-compliance with organisational obligations or arrangements not operating to the participating person’s benefit can prompt the Secretary to direct that the Chief Executive Medicare decline payments to the organisation (s 22(7)-(8)). Organisations should keep evidence of compliance to respond to any such findings.

For administrators (Chief Executive Medicare and Secretary) , operational compliance

1. Process applications against statutory criteria

• Approve applicants who meet eligibility criteria and have lodged the approved form and health professional statement (s 6(2)). Give reasons and review advice in refusal notices as required by ss 14 and 15 of the Act (s 6 note; s 9 note).

2. Conduct investigations and determinations in writing

• Undertake investigations under s 24 as necessary, and issue written determinations where the Chief Executive Medicare is satisfied a person does not meet eligibility (s 9). Always give written reasons and information about internal review rights under s 25 and s 26.

3. Manage debt recovery consistently with s 23

• Where payments were made without entitlement, recover the amount as a debt to the Commonwealth per s 23. Follow Commonwealth debt recovery procedure and provide required notices and opportunities for review.

Review and dispute handling

• Ensure review procedures and timeframes are followed. Applications for review of decisions under s 6 and s 9 must be made to the Chief Executive Medicare in writing within 28 days of receiving notice, setting out reasons (s 25(2)). For Secretary decisions under ss 21 and 22(7) provide signed notices with reasons and advice about the 28‑day review period and the option for external merits review by the Administrative Review Tribunal (s 26(2)-(7)).

Documentation and audit-readiness

• Maintain documentation demonstrating eligibility determinations, notices provided, bank EFT instructions, installed internal controls for organisations receiving funds, and evidence of timely notifications of changes. Organisations should maintain an audit trail to avoid s 22(7) directions.

Practical checklist summary

• Confirm medical condition is listed in Schedule and meets permanent and severe incontinence definition (s 4(1); s 5).
• Confirm Pensioner Concession Card or DVA card status (s 5(1)).
• Obtain a correctly prepared and signed health professional statement (s 6(2)(c)(i)).
• Complete and lodge the approved form with bank details and any nomination of authorised payment recipient (s 6; s 12(2)(b); s 20(2)).
• If an organisation is the agent, ensure ABN, accepted role in approved form, and compliant record-keeping and refund processes (s 22(2)-(6)).
• Notify Chief Executive Medicare promptly of changes affecting eligibility and of death (ss 7-8).
• Meet review timelines if aggrieved (s 25; s 26).

Following these steps will align applicants, representatives and organisations with the Instrument’s formal duties and reduce the risk of overpayment, payment denial or other administrative enforcement under ss 22 and 23.